GSK has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today, GlaxoSmithKline PLC's share price is $39.82. GlaxoSmithKline PLC's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2015 was $1.50. Hence, GlaxoSmithKline PLC's Price-to-Free-Cash-Flow Ratio for today is 26.55.
During the past 13 years, GlaxoSmithKline PLC's highest Price-to-Free-Cash-Flow Ratio was 41.33. The lowest was 8.21. And the median was 16.81.
During the past 12 months, the average Free Cash Flow per Share Growth Rate of GlaxoSmithKline PLC was -46.60% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was -10.30% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -7.70% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 2.30% per year.
During the past 13 years, GlaxoSmithKline PLC's highest 3-Year average Free Cash Flow per Share Growth Rate was 39.20% per year. The lowest was -23.90% per year. And the median was 5.70% per year.
GlaxoSmithKline PLC's Price-to-Free-Cash-Flow ratio for today is calculated as
|Price-to-Free-Cash-Flow Ratio||=||Share Price||/||Free Cash Flow per Share (TTM)|
GlaxoSmithKline PLC's Share Price of today is $39.82.
GlaxoSmithKline PLC's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2015 was 0.57 (Sep. 2014 ) + 1.06 (Dec. 2014 ) + 0 (Mar. 2015 ) + -0.13 (Jun. 2015 ) = $1.50.
It can also be calculated from the numbers for the whole company:
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, managements decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
GlaxoSmithKline PLC Annual Data
GlaxoSmithKline PLC Quarterly Data
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.